Comparative Effectiveness of Bisoprolol, Carvedilol, and Metoprolol Succinate in Patients with Heart Failure and CKD

Cheng-Wei Huang^{1

2}, Albert S Yu³, Hui Zhou^{2

4}, Katherine Pak⁴, Sally F Shaw⁴, Jiaxiao Shi⁴, Benjamin I Broder⁵, John J Sim^{2

4

6}

Affiliations

¹ Department of Hospital Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
² Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
³ Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
⁴ Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
⁵ Department of Quality and Clinical Analysis, Southern California Permanente Medical Group, Pasadena, California.
⁶ Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.

Cheng-Wei Huang et al. Clin J Am Soc Nephrol. 2025.

. 2025 Jan 1;20(1):136-138.

doi: 10.2215/CJN.0000000000000562. Epub 2024 Sep 6.

Cheng-Wei Huang^{1

2}, Albert S Yu³, Hui Zhou^{2

4}, Katherine Pak⁴, Sally F Shaw⁴, Jiaxiao Shi⁴, Benjamin I Broder⁵, John J Sim^{2

4

6}

¹ Department of Hospital Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
² Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
³ Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
⁴ Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
⁵ Department of Quality and Clinical Analysis, Southern California Permanente Medical Group, Pasadena, California.
⁶ Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.

No abstract available

Conflict of interest statement

Disclosure forms, as provided by each author, are available with the online version of the article at http://links.lww.com/CJN/C14.

1. Heidenreich PA Bozkurt B Aguilar D, et al. . 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):E895–E1032. doi:10.1161/CIR.0000000000001063 - DOI - PubMed
1. Assimon MM, Brookhart MA, Fine JP, Heiss G, Layton JB, Flythe JE. A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis. Am J Kidney Dis. 2018;72(3):337–348. doi:10.1053/J.AJKD.2018.02.350 - DOI - PMC - PubMed
1. Wu PH Lin YT Liu JS, et al. . Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis. Clin Kidney J. 2021;14(3):983–990. doi:10.1093/CKJ/SFAA248 - DOI - PMC - PubMed
1. Yu AS Pak KJ Zhou H, et al. . All-cause and cardiovascular-related mortality in CKD patients with and without heart failure: a population-based cohort study in Kaiser Permanente Southern California. Kidney Med. 2023;5(5):100624. doi:10.1016/j.xkme.2023.100624 - DOI - PMC - PubMed
1. Sim JJ Zhou H Shi J, et al. . Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters. Int Urol Nephrol. 2018;50(5):963–971. doi:10.1007/S11255-018-1837-6 - DOI - PMC - PubMed